Rapamycin and trametinib: a rational combination for treatment of NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin and trametinib: a rational combination for treatment of NSCLC

Published:2021 Issue:12 Volume:17 Page:3211-3223
ISSN:1449-2288
Container-title:International Journal of Biological Sciences
language:en
Short-container-title:Int. J. Biol. Sci.

Author:

Sun Chao-Yue,Li Yi-Zhuo,Cao Di,Zhou Yu-Feng,Zhang Mei-Yin,Wang Hui-Yun

Publisher

Ivyspring International Publisher

Subject

Cell Biology,Developmental Biology,Molecular Biology,Applied Microbiology and Biotechnology,Ecology, Evolution, Behavior and Systematics

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapeutic Strategies for the Treatment of Cancer;Cancers;2024-01-22

2. Direct Synthesis of N‐Alkyl‐2‐Pyridones Using 2‐Halogenated Pyridines;European Journal of Organic Chemistry;2024-01-16

3. Potential drug–drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma;Expert Opinion on Drug Metabolism & Toxicology;2023-08-03

4. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus;Hematological Oncology;2023-06-10

5. Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma;Thoracic Cancer;2023-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP